Recordati Industria Chimica e Farmaceutica S.p.A.

Recordati Industria Chimica e Farmaceutica S.p.A. is a renowned pharmaceutical company specializing in the research, development, manufacture, and marketing of pharmaceuticals. Established in 1926 and headquartered in Milan, Italy, Recordati has a significant presence in the global healthcare sector, serving both primary and specialty care sectors. The company's portfolio includes proprietary pharmaceuticals and a robust pipeline of new drugs, focusing on therapeutic areas such as cardiovascular diseases, urology, gastroenterology, and rare diseases. Recordati is noted for its commitment to innovation and has cultivated a strong reputation for producing high-quality medications worldwide. It operates in over 150 countries, providing accessible healthcare solutions and contributing to public health improvement. The company's influence extends across Europe, the United States, and emerging markets, making it a pivotal player in the pharmaceutical industry. By maintaining a focus on unmet medical needs and expanding therapeutic options, Recordati plays a crucial role in enhancing patient outcomes and supporting the healthcare systems globally.